MedPath

Nitroglycerin

Nitroglycerin Sublingual Tablets USP

Approved
Approval ID

6671d89f-cc89-c03c-e053-2a91aa0aa5fa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 5, 2023

Manufacturers
FDA

Medical Purchasing Solutions, LLC

DUNS: 601458529

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nitroglycerin

PRODUCT DETAILS

NDC Product Code71872-7010
Application NumberANDA208191
Marketing CategoryC73584
Route of AdministrationSUBLINGUAL
Effective DateJune 5, 2023
Generic NameNitroglycerin

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
HYDROGENATED COTTONSEED OILInactive
Code: Z82Y2C65EA
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
NITROGLYCERINActive
Quantity: 0.4 mg in 1 1
Code: G59M7S0WS3
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nitroglycerin - FDA Drug Approval Details